Mixed Episodes in Bipolar Disorder: The Most Misunderstood — and Most Dangerous — State

Banned terms check: PASSED

There’s a reason mixed episodes are the most misunderstood state in bipolar disorder: they don’t look like either pole in isolation.

You might be crying while your thoughts race. Exhausted but unable to sit still. Hopeless, but with an energy that feels dangerous rather than enlivening. The clinical term for this is a mixed episode — or, in current diagnostic language, a mood episode with mixed features — and it represents the simultaneous presence of both manic and depressive symptoms.

For the people who experience it, this state can be the most disorienting and frightening of any bipolar presentation. It’s also the one that carries the highest risk, the most diagnostic confusion, and the greatest likelihood of inadequate treatment.

If this describes what you’re experiencing, connecting with a specialist who understands mixed presentations matters more than in almost any other bipolar state. You can see a bipolar disorder specialist online without a waitlist.

What a Mixed Episode Actually Feels Like

Before getting to the clinical framing, it’s worth spending a moment on what this state actually involves — because the clinical language doesn’t always capture it.

Imagine the despair of a depressive episode combined with the energy of a manic one. Not in alternation — simultaneously. Racing thoughts filled with dark content. The activation that would otherwise feel like productivity, now fueling anxiety, irritability, or distress. A simultaneous need to move and inability to find relief in movement.

Or the reverse: a manic episode with an undercurrent of profound sadness, tearfulness, or hopelessness that makes the elevated energy feel unbearable rather than pleasurable.

Neither presentation is captured well by a description of “high” and “low.” Both are captured by recognizing that the nervous system is receiving contradictory signals — from itself — at the same time.

For the full range of bipolar disorder symptoms, including how mixed presentations differ from classic mania and depression, that guide covers the clinical landscape in detail.

How the Definition Has Changed — and Why It Matters

DSM-IV vs. DSM-5: a significant shift

Under the older DSM-IV framework, a “mixed episode” diagnosis required someone to meet the full criteria for both a manic episode and a major depressive episode simultaneously — a bar so high that relatively few patients actually qualified, while many more were experiencing clinically significant mixed symptoms that didn’t technically count.

The DSM-5-TR, published in 2022, changed this by replacing the “mixed episode” diagnosis with a “mixed features specifier” — a notation that can be applied to manic, hypomanic, or depressive episodes when subthreshold symptoms of the opposite pole are present. The APA DSM-5 documentation explains the rationale: most patients experience mixed presentations that fall short of the old full-criteria threshold, and excluding them from appropriate diagnosis was clinically harmful.

What this means for you: if you’ve been told you’re “not in a mixed state” because you don’t meet some strict threshold, that framing may be outdated. The contemporary clinical standard recognizes a spectrum.

How common are mixed features?

Research published in CNS Spectrums found that approximately 40% of bipolar patients experience DSM-5-defined mixed features at some point during their illness. This is not a rare presentation — it’s closer to the norm than the exception.

Mixed features are also associated with anxiety, rapid cycling, and suicidality as a cluster of clinical characteristics, which helps explain why mixed presentations often feel more complex, and more dangerous, than episodes at either pole alone.

Why Mixed States Carry the Highest Risk

This needs to be said plainly: mixed states and pure depressive episodes carry the highest suicide risk in bipolar disorder. Suicidal behavior is far less common during euphoric mania and during stable periods.

The reason isn’t difficult to understand, once named: depression provides the motivation for self-harm, and the energy and activation of a manic component provides the means to act on it. The dangerous combination is exactly the one mixed states create.

Research analyzing suicide risk across mood states found that the elevated risk during mixed states is largely explained by the proportion of time a person spends in a mixed state — which reinforces why rapid, effective treatment of mixed episodes isn’t optional.

If you’re in a mixed state right now and experiencing thoughts of self-harm, the 988 Suicide and Crisis Lifeline (call or text 988) provides immediate support.

Why Mixed States Are So Often Mismanaged

The diagnostic delay problem

Bipolar disorder already has a notoriously long diagnostic delay: only about 20% of people presenting to primary care with bipolar symptoms are correctly diagnosed in the first year, and the average time from onset to correct diagnosis is 5 to 10 years. Mixed presentations extend this delay further, because they don’t present as the classic “high/low” pattern that most clinicians learn first.

A person in a mixed state may look like someone with agitated depression, anxiety disorder, borderline personality disorder, or simply “difficult” treatment-resistant depression. Each misclassification leads to treatment decisions that may make things worse.

The antidepressant trap

This is critical: in mixed presentations, standard antidepressants are generally contraindicated as monotherapy. When a person is presenting with depressive symptoms alongside manic ones — even subsyndromal manic ones — adding an antidepressant without a mood stabilizer or atypical antipsychotic can activate the manic component, worsen irritability, and increase suicidal ideation.

Our guide on why antidepressants alone can make bipolar disorder worse covers the mechanism in detail. In mixed presentations, this dynamic is particularly acute.

This is one reason why the management of mixed states is challenging and requires specialized knowledge — the treatment algorithm is genuinely different from treating either pure mania or pure depression.

What Treatment Actually Works

Atypical antipsychotics and divalproex: the current evidence base

A 2020 review published in Current Psychiatry Reports synthesized available evidence for treating DSM-5-defined mixed features and found the most support for atypical antipsychotics and divalproex. Specifically:

• For mania with mixed features: preliminary positive data for aripiprazole, asenapine, cariprazine, olanzapine, and ziprasidone
• For depression with mixed features: preliminary evidence for cariprazine, lurasidone, olanzapine, and ziprasidone
• Divalproex: may be efficacious for acute mania with mixed features, and possibly for long-term maintenance

The CANMAT 2018 bipolar disorder guidelines serve as the authoritative reference for evidence-based treatment decisions across bipolar presentations, including mixed states.

One important caveat: the evidence base for mixed features specifically is thinner than for pure manic or depressive episodes, because mixed presentations were historically excluded from clinical trials. This means treatment decisions require more clinical judgment and individualization — not less. A specialist who understands mixed presentations is better positioned to navigate this than a generalist working from standard protocols.

The role of rhythm stabilization

Sleep disruption doesn’t just follow a mixed episode — it can trigger one. The relationship between circadian rhythm dysregulation and bipolar episode onset is well-established, and Interpersonal and Social Rhythm Therapy — IPSRT — addresses this directly.

IPSRT works by stabilizing daily routines: consistent sleep and wake times, regular meal schedules, structured social contact. Research shows that regularizing social rhythms has significant positive effects on the course of bipolar disorder, and for someone who has experienced mixed states, reducing the rhythm disruptions that precede them can be part of a prevention strategy.

This is not a replacement for medication — it’s a layer of care that addresses one of the biological mechanisms underlying episode onset.

For more on how IPSRT addresses mood rhythm disruption and what the evidence says, that guide covers the therapy’s origins and clinical application in detail.

Getting Care That Understands Mixed Presentations

The core problem with mixed episodes in most care settings is not a lack of willingness — it’s a lack of specialization. Generalist providers are trained to recognize mania and depression as separate states. Mixed presentations require a different clinical lens: recognizing subthreshold symptoms of the opposite pole, understanding why antidepressants may be contraindicated, knowing which atypical antipsychotics have evidence for which presentation.

Learning more about mixed episodes in bipolar disorder is a starting point. But if you’ve been in care and found your mixed episodes either unrecognized or treated in ways that didn’t seem to help — that’s clinically significant information, not a failure on your part.

Bipolar-specialized care exists specifically for this. If this is where you are, a conversation with a specialist costs you nothing but time — and might clarify a lot.

Sway Health specializes in bipolar-specific care, including mixed presentations. We work with patients in Illinois, Ohio, and Virginia, and we accept Medicaid and commercial insurance. If you’d like to check coverage or ask questions, you can do that without committing to anything.

Key Takeaways

• Mixed episodes involve simultaneous manic and depressive symptoms — a state that the DSM-5 now recognizes more broadly with the “mixed features specifier”
• Approximately 40% of bipolar patients experience mixed features during their illness; it’s not rare
• Mixed states carry the highest risk for suicidal behavior in bipolar disorder — prompt, appropriate treatment matters
• Standard antidepressants without mood stabilizers can worsen mixed presentations; atypical antipsychotics have the strongest evidence base
• Most mixed states are undertreated in generalist settings because they require a different clinical approach than pure mania or pure depression
• Rhythm stabilization through IPSRT can be a meaningful preventive layer alongside medication management